IADE: a system for intelligent automatic design of bioisosteric analogs
- 3.9k Downloads
IADE, a software system supporting molecular modellers through the automatic design of non-classical bioisosteric analogs, scaffold hopping and fragment growing, is presented. The program combines sophisticated cheminformatics functionalities for constructing novel analogs and filtering them based on their drug-likeness and synthetic accessibility using automatic structure-based design capabilities: the best candidates are selected according to their similarity to the template ligand and to their interactions with the protein binding site. IADE works in an iterative manner, improving the fitness of designed molecules in every generation until structures with optimal properties are identified. The program frees molecular modellers from routine, repetitive tasks, allowing them to focus on analysis and evaluation of the automatically designed analogs, considerably enhancing their work efficiency as well as the area of chemical space that can be covered. The performance of IADE is illustrated through a case study of the design of a nonclassical bioisosteric analog of a farnesyltransferase inhibitor—an analog that has won a recent “Design a Molecule” competition.
KeywordsIADE Bioisosteric design Scaffold hopping Chemical space Automated iterative drug design
The authors would like to acknowledge help of colleagues Peter Gedeck, Nikolaus Stiefl and Marc Litherland who helped with the implementation of IADE. Several colleagues at Novartis acted as test users and early adopters, particularly Simona Cotesta, Paulette Greenidge, Hanneke Jansen, Anna Vulpetti, Bernard Pirard and Finton Sirockin. We would like to thank also Cresset Group for help with the use of command line FieldAlign and for organizing the “Design a Molecule” competition.
- 2.Lewis RA (2012) The development of molecular modelling programs: the use and limitations of physical models. In: Livingstone DJ, Davis AM (eds) Drug design strategies: quantitative approaches. RSC Publishing, Cambridge, pp 88–107Google Scholar
- 6.Weber L, Almstetter M (1999) Diversity in very large libraries. In: Dean PM, Lewis RA (eds) Molecular diversity in drug design. Kluwer, pp 93-114Google Scholar
- 12.Weininger D (1995) Method and apparatus for designing molecules with desired properties by evolving successive populations. U.S. Patent No. 5,434,796Google Scholar
- 23.CORINA version 3.20, Molecular Networks GmbH, Erlangen, GermanyGoogle Scholar
- 24.FieldAlign version 3.01, Cresset Group, Welwyn Garden City, UKGoogle Scholar
- 25.Glide, version 5.8, Schrödinger, Inc., New York, NY, USAGoogle Scholar
- 28.Hast MA, Fletcher S, Cummings CG, Pusateri EE, Blaskovich MA, Rivas K, Gelb MH, Van Voorhis WC, Sebti SM, Hamilton AD, Beese LS (2009) Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase. Chem Biol 16:181–192CrossRefGoogle Scholar